Essential role of vif in establishing productive HIV-1 infection in peripheral blood T lymphocytes and monocyte/macrophages - PubMed (original) (raw)
Affiliations
- PMID: 7519673
Essential role of vif in establishing productive HIV-1 infection in peripheral blood T lymphocytes and monocyte/macrophages
D H Gabuzda et al. J Acquir Immune Defic Syndr (1988). 1994 Sep.
Abstract
The role of vif during the establishment of human immunodeficiency virus type 1 (HIV-1) infection of peripheral blood T lymphocytes and monocyte/macrophages was investigated using vif mutants of three HIV-1 proviral DNAs. Vif was found to be essential for the establishment of productive HIV-1 infection in peripheral blood T lymphocytes after cell-free infection with HXB2 and DFCI-HD, a vpr-positive, vpu-positive, nef-positive derivative of HXB2. A chimeric HIV-1 provirus in which the T-cell line-tropic env sequences in DFCI-HD were replaced with the macrophagetropic env of the ADA strain was constructed for studies on the role of vif during the establishment of HIV-1 infection in primary monocyte/macrophages. These studies showed that vif is also essential for the initiation of productive HIV-1 infection in primary monocyte/macrophage cultures after cell-free virus transmission. The DFCI-HD-ADA virus was shown to replicate in the CD4+ T-cell line Molt 4 clone 8 but not in other T-cell or monocytic cell lines, as previously shown for another macrophagetropic strain YU-2 (1), suggesting that this cell line may be useful for future studies on at least some macrophagetropic strains of HIV-1. The finding that vif is essential for the establishment of productive HIV-1 infection in primary T lymphocytes and monocyte/macrophages suggests that vif may be required for HIV-1 transmission and disease pathogenesis during natural infections and thus may be a good target for prophylactic or therapeutic intervention.
Similar articles
- gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants.
D'Aloja P, Olivetta E, Bona R, Nappi F, Pedacchia D, Pugliese K, Ferrari G, Verani P, Federico M. D'Aloja P, et al. J Virol. 1998 May;72(5):4308-19. doi: 10.1128/JVI.72.5.4308-4319.1998. J Virol. 1998. PMID: 9557721 Free PMC article. - Prolonged infection of peripheral blood lymphocytes by Vif-negative HIV type 1 induces resistance to productive HIV type 1 infection through soluble factors.
Simm M, Pekarskaya O, Potash MJ, Volsky DJ. Simm M, et al. AIDS Res Hum Retroviruses. 2000 Jul 1;16(10):943-52. doi: 10.1089/08892220050058353. AIDS Res Hum Retroviruses. 2000. PMID: 10890355 - vif-negative human immunodeficiency virus type 1 persistently replicates in primary macrophages, producing attenuated progeny virus.
Chowdhury IH, Chao W, Potash MJ, Sova P, Gendelman HE, Volsky DJ. Chowdhury IH, et al. J Virol. 1996 Aug;70(8):5336-45. doi: 10.1128/JVI.70.8.5336-5345.1996. J Virol. 1996. PMID: 8764044 Free PMC article. - The role of Vif during HIV-1 infection: interaction with novel host cellular factors.
Lake JA, Carr J, Feng F, Mundy L, Burrell C, Li P. Lake JA, et al. J Clin Virol. 2003 Feb;26(2):143-52. doi: 10.1016/s1386-6532(02)00113-0. J Clin Virol. 2003. PMID: 12600646 Review. - The Vif protein of human immunodeficiency virus type 1 (HIV-1): enigmas and solutions.
Baraz L, Kotler M. Baraz L, et al. Curr Med Chem. 2004 Jan;11(2):221-31. doi: 10.2174/0929867043456124. Curr Med Chem. 2004. PMID: 14754418 Review.
Cited by
- HIV-1 Vif Triggers Cell Cycle Arrest by Degrading Cellular PPP2R5 Phospho-regulators.
Salamango DJ, Ikeda T, Moghadasi SA, Wang J, McCann JL, Serebrenik AA, Ebrahimi D, Jarvis MC, Brown WL, Harris RS. Salamango DJ, et al. Cell Rep. 2019 Oct 29;29(5):1057-1065.e4. doi: 10.1016/j.celrep.2019.09.057. Cell Rep. 2019. PMID: 31665623 Free PMC article. - HIV-1 restriction by endogenous APOBEC3G in the myeloid cell line THP-1.
Ikeda T, Molan AM, Jarvis MC, Carpenter MA, Salamango DJ, Brown WL, Harris RS. Ikeda T, et al. J Gen Virol. 2019 Jul;100(7):1140-1152. doi: 10.1099/jgv.0.001276. Epub 2019 May 30. J Gen Virol. 2019. PMID: 31145054 Free PMC article. - Feline APOBEC3s, Barriers to Cross-Species Transmission of FIV?
Zhang Z, Gu Q, Marino D, Lee KL, Kong IK, Häussinger D, Münk C. Zhang Z, et al. Viruses. 2018 Apr 10;10(4):186. doi: 10.3390/v10040186. Viruses. 2018. PMID: 29642583 Free PMC article. Review. - Core Binding Factor β Protects HIV, Type 1 Accessory Protein Viral Infectivity Factor from MDM2-mediated Degradation.
Matsui Y, Shindo K, Nagata K, Yoshinaga N, Shirakawa K, Kobayashi M, Takaori-Kondo A. Matsui Y, et al. J Biol Chem. 2016 Nov 25;291(48):24892-24899. doi: 10.1074/jbc.M116.734673. Epub 2016 Oct 7. J Biol Chem. 2016. PMID: 27758855 Free PMC article. - Small molecules that inhibit Vif-induced degradation of APOBEC3G.
Matsui M, Shindo K, Izumi T, Io K, Shinohara M, Komano J, Kobayashi M, Kadowaki N, Harris RS, Takaori-Kondo A. Matsui M, et al. Virol J. 2014 Jul 1;11:122. doi: 10.1186/1743-422X-11-122. Virol J. 2014. PMID: 24986077 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials